JP2016504315A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016504315A5 JP2016504315A5 JP2015547441A JP2015547441A JP2016504315A5 JP 2016504315 A5 JP2016504315 A5 JP 2016504315A5 JP 2015547441 A JP2015547441 A JP 2015547441A JP 2015547441 A JP2015547441 A JP 2015547441A JP 2016504315 A5 JP2016504315 A5 JP 2016504315A5
- Authority
- JP
- Japan
- Prior art keywords
- dengue
- immunogenic composition
- combination
- virus
- trivalent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261737679P | 2012-12-14 | 2012-12-14 | |
| US61/737,679 | 2012-12-14 | ||
| PCT/US2013/073757 WO2014093182A1 (en) | 2012-12-14 | 2013-12-07 | Compositions, methods of administration and uses for trivalent dengue virus formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016504315A JP2016504315A (ja) | 2016-02-12 |
| JP2016504315A5 true JP2016504315A5 (enExample) | 2017-01-26 |
Family
ID=50934851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015547441A Pending JP2016504315A (ja) | 2012-12-14 | 2013-12-07 | 三価デングウイルス製剤に関する組成物、投与方法および使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US9878031B2 (enExample) |
| EP (1) | EP2931310A4 (enExample) |
| JP (1) | JP2016504315A (enExample) |
| CA (1) | CA2933472A1 (enExample) |
| WO (1) | WO2014093182A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2968516B1 (en) | 2013-03-15 | 2022-01-12 | Takeda Vaccines, Inc. | Compositions and methods for dengue virus chimeric constructs in vaccines |
| WO2016130786A2 (en) * | 2015-02-15 | 2016-08-18 | Integral Molecular, Inc. | Flaviviridae proteins and virions and methods of use thereof |
| JP2019511533A (ja) * | 2016-04-13 | 2019-04-25 | タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. | 小児及び若年成人のデングウイルスに対するワクチンの組成物及び方法 |
| EP3846849A1 (en) * | 2018-09-05 | 2021-07-14 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
| US11426461B2 (en) | 2018-09-05 | 2022-08-30 | Takeda Vaccines, Inc. | Methods for preventing dengue and hepatitis A |
| US11464815B2 (en) | 2018-09-05 | 2022-10-11 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
| BR112022001476A2 (pt) * | 2019-08-16 | 2023-10-03 | Takeda Vaccines Inc | Uso de uma vacina contra hepatite a e uma composição de vacina contra dengue ou uma dose unitária de uma composição de vacina contra dengue, combinação de vacina e kit |
| WO2024108087A1 (en) * | 2022-11-18 | 2024-05-23 | Takeda Vaccines, Inc. | A method for determining the proportion of a live, attenuated flavivirus having a nucleotide sequence comprising at least one attenuation locus in a formulation |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE526411T1 (de) * | 2000-02-16 | 2011-10-15 | Us Gov Health & Human Serv | Avirulente, immunogene flavivirus-chimäre |
| US20040120964A1 (en) | 2001-10-29 | 2004-06-24 | Mikszta John A. | Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses |
| US20040259224A1 (en) | 2002-05-31 | 2004-12-23 | Farshad Guirakhoo | Tetravalent Dengue vaccines |
| SG156666A1 (en) | 2004-10-20 | 2009-11-26 | Acambis Inc | Vaccines against japanese encephalitis virus and west nile virus |
| CA2611954C (en) | 2005-06-17 | 2014-01-28 | Sanofi Pasteur | Dengue serotype 2 attenuated strain |
| CN101238144B (zh) * | 2005-06-17 | 2012-09-05 | 赛诺菲巴斯德有限公司 | 登革血清型1减毒株 |
| JP5227172B2 (ja) | 2005-08-10 | 2013-07-03 | サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー | デングウイルス感染に対するワクチン接種 |
| PL2589602T3 (pl) | 2006-08-15 | 2016-11-30 | Rozwinięcie komponentów szczepionki przeciwko wirusowi dengi | |
| FR2906724B1 (fr) * | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
| US20100316670A1 (en) | 2007-06-14 | 2010-12-16 | Blaney Joseph E | Chimeric sle/dengue type 4 antigenic viruses |
| WO2010085358A2 (en) | 2009-01-23 | 2010-07-29 | The Board Of Regents Of The University Of Texas System | Flaviviruses expressing the prm, e, and ns1 proteins of other flaviviruses and uses thereof |
| AU2010256845B2 (en) * | 2009-06-01 | 2016-09-22 | Takeda Vaccines, Inc. | Compositions and methods for administration of vaccines against dengue virus |
| US8968996B2 (en) * | 2009-06-01 | 2015-03-03 | Takeda Vaccines, Inc. | Compositions and methods for rapid immunization against dengue virus |
| WO2012065105A2 (en) | 2010-11-12 | 2012-05-18 | Thomas Monath | Chimeric flavivirus vaccines |
| JP2015520196A (ja) * | 2012-06-10 | 2015-07-16 | タケダ ワクチン, インコーポレイテッドTakeda Vaccines, Inc. | デングウイルスに対するワクチン投与のための組成物および方法 |
-
2013
- 2013-12-07 US US14/652,066 patent/US9878031B2/en not_active Expired - Fee Related
- 2013-12-07 WO PCT/US2013/073757 patent/WO2014093182A1/en not_active Ceased
- 2013-12-07 EP EP13863155.1A patent/EP2931310A4/en not_active Withdrawn
- 2013-12-07 JP JP2015547441A patent/JP2016504315A/ja active Pending
- 2013-12-07 CA CA2933472A patent/CA2933472A1/en not_active Abandoned
-
2017
- 2017-12-15 US US15/844,030 patent/US20180228887A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016504315A5 (enExample) | ||
| JP2013542224A5 (enExample) | ||
| JP2019151636A5 (enExample) | ||
| ATE526411T1 (de) | Avirulente, immunogene flavivirus-chimäre | |
| JP2015535302A (ja) | ビリオン分解に影響を及ぼすフラビウイルスのエンベロープタンパク質変異 | |
| KR20130138789A (ko) | 재조합 서브유닛 뎅기 바이러스 백신 | |
| AU2017250696A1 (en) | Compositions and methods of vaccination against dengue virus in children and young adults | |
| NZ597000A (en) | Compositions and methods for administration of vaccines against dengue virus | |
| JP2017526689A5 (enExample) | ||
| Sim et al. | Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen | |
| WO2017156511A8 (en) | Live attenuated zika virus vaccine | |
| US9861692B2 (en) | Dengue virus vaccine compositions and methods of use thereof | |
| JP2019520090A (ja) | 弱毒変異型ジカウイルスを含むワクチン組成物 | |
| EP3590955A1 (en) | Methods and compositions for dengue virus vaccines | |
| EP3236997B1 (en) | Dengue virus vaccine compositions and methods of use thereof | |
| EP3481848B1 (en) | Genomic sequences encoding for an attenuated mutant zika virus | |
| Roberts et al. | New opportunities for control of dengue virus | |
| JP5657204B2 (ja) | デングウイルスのカプシドタンパク質を有する、デングウイルスに対する防御反応を誘導することができる医薬品組成物 | |
| ES2551699T3 (es) | Composiciones, procedimientos y kits | |
| CN103352047B (zh) | 旋毛虫肌幼虫es抗原基因疫苗及其制备方法 | |
| Li et al. | Comparison of the efficacy and safety of different immunization routes induced by human respiratory syncytial virus F protein with CpG adjuvant in mice | |
| JP2014524450A5 (enExample) | ||
| López et al. | New evidence on the virus capsid as a vaccine candidate against the Dengue 2 virus without the induction of the neutralizing antibodies | |
| Caine | Understanding host adaptation and disease progression of enterovirus 71 using mouse models, reverse genetics, and in vivo imaging | |
| TH91621B (th) | วิธีการของการก่อภูมิคุ้มกันโรคเพื่อต่อต้าน 4 ซีโรไทป์ของไข้เลือดออก |